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ABSTRACT The early steps of crystal nucleation and growth in Brome Mosaı¨c virus and polyethylene glycol mixtures were
analyzed using time-resolved x-ray scattering (at the European Synchrotron Radiation Facility, Grenoble, France). The system
was chosen as a crystallization model since the phase diagram of the macromolecule/polymer mixture was known to present, at
high polymer concentration, a solid, precipitated phase made of the synchronized formation of a large number of microcrystals.
The precipitation and crystallization of the samples was induced by the controlled mixing of virus and polymer using a stopped-
ﬂow device. Appearance and growth of Bragg diffraction peaks were used to follow the crystal nucleation and growth as
a function of time, virus and polymer concentration, and polymer size. In all samples, the crystallization starts after a few
seconds and proceeds for ;1–20 min until there is almost no virus left in the solution. The crystalline system was found to be
face-centered cubic, with a unit cell size of 391 A˚. The data analysis allowed us to show the presence of viruses in only two
states, in solution or in crystals, revealing that the formation of periodic order proceeds without any detectable intermediate
amorphous state.
INTRODUCTION
The limiting step in x-ray protein crystallography remains
nucleation and crystal growth, the mechanisms of which are
not yet completely understood and thus rather poorly
controlled. In particular, the earliest steps necessary to make
a nucleus, which will grow into a well-developed crystal, are
just becoming accessible. In a previous work (Casselyn et al.,
2001) the Brome Mosaı¨c virus (BMV) was used to study
with small-angle x-ray scattering (SAXS) the inﬂuence of
salt and polyethylene glycol (PEG) on the crystallization of
large macromolecules. The BMV is an icosahedral plant
virus of 264 A˚ in diameter and a molecular weight of 4.6 3
106 Da, made of a T ¼ 3 protein capsid surrounding a RNA
genome. In the course of the SAXS study on this virus,
Bragg diffraction peaks were observed from the solid phase
that precipitates out of the solution when a high concentra-
tion of PEG is added, demonstrating that the precipitates
were microcrystals. The phenomenon had occurred during
the few minutes necessary to prepare our samples, inject
them into the sample holder, and record an x-ray spectrum.
The microcrystalline precipitates were obtained when using
PEG, either alone or combined with salts. The position of the
diffraction peaks was conserved, whatever the PEG size, or
the presence of salt, revealing that the crystalline system was
the same. The system was therefore particularly suited to
analyze the ﬁrst steps of macromolecular nucleation and
growth.
PEG is a nondenaturing agent that was used in the past to
precipitate viruses as a puriﬁcation process, and is now in the
process to become the most utilized crystallizing agent. After
the initial proposal by George and Wilson (1994) that
crystallization occurs in a narrow range of second virial
coefﬁcients, it is now well established that crystallization
occurs in or close to attractive regimes (see Finet et al.,
2003). The attraction allows macromolecules to come close
to each other and experience contacts. The addition of
neutral polymers to colloid solutions results in a nonspeciﬁc
attractive potential between colloids, called the depletion
attraction, dependent upon polymer size and concentration
(Asakura and Oosawa, 1958; Poon et al., 1996; Ye et al.,
1996). After some pioneering studies (Mahadevan and Hall,
1990), the effect of PEG in solutions of biological macro-
molecules has now been thoroughly investigated (Budayova
et al., 1999; Kulkarni et al., 2000; Bonnete´ et al., 2001; Finet
and Tardieu, 2001; Tardieu et al., 2002; Vivare`s et al., 2002;
Finet et al., 2003; Vivare`s and Bonnete´, 2004). As the
distance between two macromolecules becomes smaller than
the polymer diameter, the PEG molecules get excluded from
this region. The resulting unbalanced osmotic pressure is
equivalent to a macromolecular attraction, which drives the
macromolecules toward each other. Thereby, the addition of
PEG may modify the phase diagram boundaries, induce
either liquid-liquid or liquid-solid phase separations and act
on the kinetics of the process, e.g., on the precipitation/
nucleation rate (Galkin and Vekilov, 2000), as observed with
Brome Mosaı¨c virus (BMV) in previous studies. Indeed, the
phase diagrams determined with microbatch experiments
with either PEG 8000 or PEG 20,000 (Casselyn et al., 2001)
showed essentially three phases. The solubility curve
delineates, as usual, the region where the solution is
undersaturated and the virus soluble, and the region of
supersaturation where the growth of large crystals may
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occur. When the PEG concentration increases, the depletion
attraction becomes stronger and leads to a phase separation,
which in our case results in the precipitation of micro-
crystals. At a given pH, the phase transition boundaries have
been observed to shift as a function of the PEG molecular
weight. Finally, the making of a stable crystal requires
in addition the formation of speciﬁc contacts, which
generally imply some dehydration. So far, the building of
crystallographic symmetry has remained largely unknown
(Wukovitz, 1996). The massive formation of microcrystals
at high PEG concentration was an opportunity to understand
more about the early steps of crystal nucleation and
growth.
On the experimental side, despite the number of attempts,
only in a few cases have putative nuclei been observed (Yau
and Vekilov, 2000, 2001; Petsev et al., 2003). On the
theoretical and computational sides, however, many studies
have been performed that yielded hypotheses on the
nucleation pathway.
Classical nucleation theory assumes that the critical nuclei
should have a spherical shape, due to the surface tension,
with the same crystalline organization as in the stable bulk
crystal (Boistelle and Astier, 1988; ten Wolde and Frenkel,
1997). The critical nucleus is characterized by its radius, Rc,
the value of which depends upon the solution supersaturation
s ¼ ln(c/cs) (where c is the concentration and cs the
solubility of the protein), and on the physicochemical
conditions. The nucleus will tend to redissolve if it loses a
molecule, whereas the binding of a molecule will trigger the
nucleus growth. Computer simulations for globular proteins
(ten Wolde and Frenkel, 1997; Oxtoby, 1998; Talanquer
and Oxtoby, 1998) introduced the notion of a metastable
critical point that depends on a critical crystallization
temperature Tc, where the free-energy barrier is the lowest
for nucleation and leads to optimal crystal growth. Close
to this point, an amorphous critical nucleus would consist
in the disordered aggregation of a few molecules, and
the crystallinity would appear later during the growth pro-
cess. By varying the temperature and thus moving away from
Tc, the free-energy barrier increases, still allowing nucleation,
yet with nuclei having the same organization as in the
crystal.
Experimentally, critical nuclei are not easily accessible.
Light scattering has been used to investigate the early steps
of nucleation of some globular or spherical macromolecules,
yet far from phase separation, i.e., in solution conditions
where only a small number of nuclei can grow into
observable crystals. The idea was to look for the formation
of aggregates that could be the desired critical nuclei (Malkin
and McPherson, 1994). Among them, Satellite Tobacco
Mosaı¨c virus (STMV), a spherical plant virus of 160 A˚ in
diameter, and apoferritin, a quasispherical protein of 130 A˚
in diameter, were studied. Aggregates were indeed observed,
and their evolution was followed as a function of the
supersaturation s. The critical radius was assumed to be the
radius of the aggregates measured when crystals started to be
visible in the solution. In the case of STMV, for s ¼ 1–1.4,
Rc was in the range of 30–50 nm corresponding to 7–30
STMV particles. For apoferritin, Rc was in the range of
40–50 nm, and the nuclei were thus thought to be composed
of 30–70 apoferritin monomers. However, one difﬁculty is
that there is no proof that the aggregates studied with light
scattering are the nuclei that yield crystals. Moreover, light
scattering cannot tell us whether the aggregates are
amorphous or crystal-like. AFM now allows us to visualize
biological macromolecules at the nanometer scale. It has
already been used to visualize the crystal growth process of
different macromolecular crystals (Malkin et al., 1995,
1999; Li et al., 1999; Kuznetsov et al., 2000; McPherson
et al., 2000; Yau et al., 2000; McPherson et al., 2001; Yau
and Vekilov, 2001). In the case of apoferritin, it has also
been used to observe the formation in solution of the
clusters at the origin of crystals (Yau and Vekilov, 2000). In
this particular case, the nuclei have a size close to that
predicted by Malkin and McPherson (1994). They appear
planar rather than spherical, and made of several rods of
molecules with the same molecular arrangement as in the
crystals.
In the present study, we performed time-resolved small-
angle x-ray scattering (SAXS) experiments on the ID2
beamline of the European Synchrotron Radiation Facility
(ESRF) to follow the formation of BMV microcrystals.
Preliminary results of these experiments were presented
elsewhere (Casselyn et al., 2002). The beamline is equipped
with a fast two-dimensional detector and a stopped-ﬂow
device (Narayanan et al., 2001) that permitted the rapid
mixing of three components (virus, PEG, and solvent) and
injection under the x-ray beam. The precipitation of the viral
solutions at various concentrations was induced by the use of
three PEGs of different molecular weight, 3350 Da, 8000 Da,
or 20,000 Da, at pH 5.9 and room temperature. The 50-ms-
long measurements were carried out with exponentially
spaced intervals from 180 ms after the mixing up to 10 or 25
min, according to the sample composition. These experi-
ments allowed us to follow the kinetics of early growth of
BMV microcrystals as a function of the PEG size and
concentration.
MATERIAL AND METHODS
Sample preparation
BMV was puriﬁed from infected barley leaves as previously described
(Casselyn et al., 2001), and concentrated at 40 mg/ml. The virions were
maintained in their storage 20 mM Na acetate (Calbiochem, EMD
Biosciences, San Diego, CA) buffer, at pH 5.9. All the experiments were
undertaken at constant pH, and at 15C. Three PEGs of molecular weights
3350 Da, 8000 Da, and 20,000 Da from Hampton Research (Riverside, CA)
were used, called in the following PEG 3 K, 8 K, and 20 K. The solutions at
concentrations 5%, 10%, and 20% (w/v) were also maintained in 20 mM Na
acetate, pH 5.9.
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Stopped-ﬂow device
The stopped-ﬂow device (Bio-Logic Science Instruments, Grenoble, France)
available on ID2 is composed of three tanks, permitting the rapid mixing,
between 3 and 10 ms, of the different components and the pushing of the
sample toward a 1.5-mm internal diameter quartz capillary. Two tanks were
ﬁlled respectively with the diluting 20 mM Na Acetate buffer at pH 5.9, and
with the PEG solutions. The third tank contained the BMV solution at
a concentration of 40 mg/ml. A software (Bio-Logic Science Instruments)
permitted the deﬁnition and the mixing of the desired volumes. The ﬁnal
concentrations obtained were 20, 10, 5, or 2.5 mg/ml virus, in presence of
10, 5, or 2.5% (w/v) PEG. The experiments were found reproducible
provided that the volumes injected were large enough. The total injected
volume of the samples was 80 ml, except for the samples at 2.5 mg/ml BMV,
where the volumes were doubled. Because of the PEG viscosity, the
capillary was cleaned several times by ﬂushing with buffer before each
series.
SAXS experiments
Beamline
SAXS experiments were performed on the ID2 beamline at ESRF
(Grenoble, France). The operating energy was of 12.5 KeV, i.e.,
a wavelength of  1 A˚, for a photon ﬂux of 1013 photons/s and a beam
size of 0.3 mm per 0.8 mm. The scattering data were recorded for scattering
vector seconds (s ¼ 2sinu/l) ranging from 1.17 103 to 3.50 102 A˚1. The
increment in seconds per channel was of 0.0865 3 103 A˚1. The
acquisition sequence followed the formula
ti ¼ ti11 tmeas1 ci2 Dtint; for i. 1 and t1 ¼ 10ms; (1)
where ti is the time after the mixing, tmeas the duration of each measurement
(50 ms) chosen to ensure a sufﬁcient signal, ci–2, and Dtint is the time interval
between two exposures calculated to cover the whole process with ;20
exposures, thus avoiding radiation damage; this time lapse is equal to 120 ms
(Dtint) between the two ﬁrst measurements and is then increased by
a coefﬁcient c (equal to 1.57 or 1.6 according to the experiments). The ﬁrst
frame was recorded 10 ms after mixing. The second, constituting the ﬁrst
reliable frame, was measured 180 ms after mixing. A fast two-dimensional
detector, i.e., x-ray image intensiﬁer coupled to a charge-coupled device
camera developed at the ESRF (the fast read-out and low-noise camera or
FReLoN; see Narayanan et al., 2001), synchronized to the fast -beam
shutter, permitted us to record two-dimensional scattering frames. All the
calculations were done with the assumption that the contribution of the
geometry of the x-ray camera to the peak width can be neglected.
SAXS data reduction
The raw two-dimensional data reduction, necessary to obtain the normalized
intensity values (one-dimensional data) as a function of the scattering vector
seconds, consist of
1. Subtraction of the CCD dark current.
2. Correction of the spatial distortion and the spatial inhomogeneities.
3. Calibration to the absolute intensity.
4. Normalization to the incident intensity, the transmission, and the sample
thickness.
5. Azimuthal integration (Narayanan et al., 2001).
The one-dimensional scattered intensity data were subtracted for corre-
sponding buffer signal. Note that all the scattering curves are on the same
scale.
THEORETICAL BASIS
Nucleation
The driving force for nucleation and growth is the difference
between the chemical potential of a macromolecule in the
crystalline state and in solution. It is usually written as
Dm ¼ kBT lnðc=csÞ; (2)
where c is the macromolecular concentration before
nucleation, cs is the solubility (i.e., the concentration at
saturation), kB is the Boltzmann’s constant, T is the
temperature, and s ¼ ln(c/cs) is the supersaturation. By
deﬁnition, a nucleus is a thermodynamically unstable
assembly that can either decay back into monomers or
continue to grow into a crystal. The energy required to form
a nucleus of volume V and area S is given by
DG ¼ ðV=VÞkBT s1 Sg; (3)
where V is the volume of the macromolecule inside the
crystal, and g is the interfacial free energy per unit area
between nucleus and solution. The ﬁrst term in Eq. 3 is
a volume term, where V/V is the number of macromolecules
inside the nucleus. The second term is the energy required to
create the nucleus surface. Because of the opposite effect
between volume and surface term DG passes through
a maximum for a ‘‘critical’’ size of the nucleus, at a given
temperature and supersaturation ratio. If we consider
a spherical nucleus, the critical radius is equal to
r
 ¼ 2Vg=kBT s: (4)
When the nucleus reaches this critical radius, the corre-
sponding free energy for nucleation is
DG
 ¼ 16pV2g3=3ðkBT sÞ2; (5a)
or
DG
 ¼ ð1=3Þð4pr2 gÞ: (5b)
X-ray scattering analysis
With monodisperse solutions of globular macromolecules in
aqueous buffer, the x-ray scattering curves (subtracted for
background), I(c,s), may be written as the product of the
particle concentration by a form factor, I(0,s) (scattered
intensity of one particle), and by a structure factor, S(c,s),
which takes into account departures from ideality, owing to
particle-particle interactions (Tardieu, 1994),
Iðc; sÞ ¼ c Ið0; sÞ Sðc; sÞ: (6)
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I(0,s) and S(c,s) are the Fourier transforms of the spherically
averaged autocorrelation functions, respectively, of the
electron density contrast associated with the particle, and
of the particle distribution function, which is the probability
to ﬁnd two particles at a distance r. The form factor gives
information on the particle shape, including its oligomeric
state. Then, the variation of the SAXS scattering curves as
a function of particle concentration readily indicates the type
of interactions, repulsive and attractive, present in solution.
With repulsive interactions, the particles are evenly distrib-
uted and the structure factor at the origin, S(c,0), is,1. With
attractive interactions, ﬂuctuations in the particle distribution
are observed and S(c,0) is .1. In a typical experiment, the
form factor is measured at low protein concentration and the
structure factor is then obtained by dividing the intensity
curve recorded at high concentration by the form factor.
In a multicomponent system (Guinier and Fournet, 1955),
the total scattered intensity becomes
Iðc; sÞ ¼ +
i
+
j
ﬃﬃﬃﬃﬃﬃﬃ
cicj
p ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Iið0; sÞIjð0; sÞ
q
Sijðc; sÞ; (7)
where the Sij(s) are the partial structure factors, which take
into account spatial correlations and thus interactions between
particles. Therefore, in the binary mixture obtained after
addition of PEG to the virus solution, the intensity becomes
Iðc; sÞ ¼ cvIvð0; sÞSvðc; sÞ
1 2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
cvcPEG
p ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Ivð0; sÞIPEGð0; sÞ
p
SvPEGðsÞ
1 cPEGIPEGð0; sÞSPEGðc; sÞ; (8)
where v stands for virus. Yet, the PEG scattering (third term)
can be ignored since, when the background is recorded with
the proper amount of PEG, the third term is part of the
background and is subtracted with it. The cross term,
although non-zero, is at most 1% of the ﬁrst one since the
intensity at the origin is proportional to the molecular weight
and to the square of the electron density contrast. As the
molecular weight of BMV is between 230 and 1500 times
larger than the PEGs used, the cross term can be neglected.
The scattered intensity (Eq. 8) therefore simpliﬁes to the ﬁrst
term, i.e., the virus scattering.
After addition of increasing amounts of PEG to the system
of volume VS, phase separation into one liquid phase of
volume V1 depleted in virus and enriched in PEG, and one
solid phase of volume V2 enriched in virus and depleted in
PEG, then occurs. The sample scattering then becomes the
sum of the scattering of the individual phases. For the
reasons given above, the PEG scattering can still be
neglected and the scattering may be simply written as
Iðc; sÞ ¼ ðc1 V1
VS
ÞIð0; sÞS1ðc1; sÞ1 ðc2 V2
VS
ÞIð0; sÞS2ðc2; sÞ;
(9)
where the subscripts 1 and 2 stand for each of the two phases
and c1 and c2 for the virus concentrations in phases 1 and 2,
respectively, with cVS ¼ c1V1 1 c2V2. Note, however, that
c1V1, c2 V2, S1(c1,s), and S2(c2,s) vary as a function of time
after mixing. In the liquid phase, since the initial virus
concentration is small and then decreases as a function of
time, S1(c1,s) remains close to 1—except perhaps at very
small angles. In the solid phase, amorphous nuclei, if any,
should scatter as a concentrated liquid phase and S2(c2,s)
should present an interference ring at a value of s close to the
inverse of the virus diameter.
As soon as the nuclei become periodically ordered,
S2(c2,s) is no longer a continuous function. The reciprocal
space is made of the (hkl) nodes of the reciprocal space of the
crystal lattice. Yet, because of the ﬁnite size of the crystals,
each node can be described as a delta function convoluted by
the Fourier transform of the crystal shape, FTSHAPE. The
corresponding intensity is (dhkl * FTSHAPE(t))
2. It is
convenient in such calculations to assume a Gaussian shape,
since the Fourier transform of a Gaussian function is also
a Gaussian function and where the width of the Bragg peaks
decreases with crystal growth, i.e., with increasing crystal
size. The intensity at the nodes is proportional to the
crystallographic structure factors jFj2(hkl). Whenever one of
the microcrystals is correctly oriented, a Bragg peak is
observed on the detector. As soon as enough microcrystals
have been formed, the x-ray diagram becomes equivalent to
a powder diagram. The spherically averaged intensity may
then be written as
Iðc; sÞ ¼ c1V1ðtÞ
V
 
Ið0; sÞ1aðtÞðdhkl
 FTSHAPEðtÞÞ2jFðhklÞj2 c c1V1ðtÞ
V
 
Ið0; sÞ; (10)
where the proportionality constant, a, accounts for the
scattering efﬁciency of the crystals, given the geometry of
the camera and the crystal shapes.
The analysis of the scattering curves should therefore help
us to analyze the ﬁrst steps of crystal nucleation and growth.
Eq. 10, however, shows that nucleation and growth may be
difﬁcult to disentangle, since they both lead to a decrease of
the virus concentration in the liquid phase. Note that the peak
shape only depends upon crystal growth and that, at the end
of the process when the system is in equilibrium, the virus
concentration in the liquid phase, c1, is equal to the virus
solubility, cs.
RESULTS
X-ray scattering experiments
The experiment is illustrated in Fig. 1, where the top of the
ﬁgure represents the characteristic two-dimensional patterns
of viruses in solution as observed on the screen during the
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experiment, and the bottom of the ﬁgure is the corresponding
scattering spectrum after data reduction and background
subtraction. As a ﬁrst step, the virus scattering was measured
as a function of the virus concentration without PEG (Fig. 1
a) to determine the form factor (Fig. 1 b). At the pH used for
the experiments, 5.9, the interactions are only slightly
repulsive and the structure factor departs from 1 only at low
angles. Therefore, at low angles (1.17 103, s, 4.62 103
A˚1), the signal of the less-concentrated sample (2.5 mg/ml)
was taken as the form factor of the virus. At larger angles, the
signal scattered by the 10 and 20 mg/ml BMV solutions was
used to complete the form factor, to improve the signal/noise
ratio in this region. It has been shown previously (Casselyn
et al., 2001) that the form factor could be accounted for by
a hollow sphere of external and internal radius of 132 and
40.5 A˚, respectively.
Yet the purpose of this study was to couple time-resolved
x-ray scattering and stopped-ﬂow experiments to follow the
ﬁrst steps of the PEG-induced BMV nucleation and growth.
The PEGs 3 K, 8 K, and 20 K were used at three different
concentrations 2.5, 5, and 10% w/v, in samples containing
2.5, 5, 10, and 20 mg/ml BMV. All these concentrations were
controlled through the stopped-ﬂow device. For each condi-
tion, 20 frames were successively recorded, exponentially
spaced in time (see Eq. 1). The conditions were repeated at
least twice to verify the reproducibility.
Fig. 1 c illustrates a typical time evolution of the two-
dimensional scattering patterns (top) and the corresponding
scattering intensities (bottom). The top of the ﬁgure shows
50-ms spectra recorded at respectively 180 ms, 5 s, and 25
min after the mixing of BMVwith PEG. The ﬁrst spectrum is
hardly distinguishable from that in Fig. 1 b. The only
difference is the presence of a few diffraction spots owing to
a few microcrystals remaining from the previous shot and
that can never be totally eliminated despite extensive rinsing.
After ;1 s, individual spots, i.e., Bragg peaks that testify to
the crystal nucleation, start to appear as can be seen on the
second spectrum of Fig. 1 c. After 20–60 s, the diffraction
spots corresponding to an increasing number of randomly
oriented microcrystals have merged to build the diffraction
rings of a crystal powder diagram as seen on the third
spectrum of Fig. 1 c. This simple visual report of the ex-
periments tends to indicate that only two phases are observed,
the solution or the crystal. Indeed, in no case could the
presence of an interference ring, that would be the signature
of an amorphous intermediary state, be detected.
As shown in Table 1, which summarizes the mixtures
tested, nucleation readily occurs with BMV concentrations
of 5 mg/ml with 10% PEG 20 K but requires higher BMV
concentrations at 10% PEG 3 K. As expected, the solubility
curves are displaced toward lower virus concentrations when
the PEG size increases. Three sets of representative data
were selected, one for each PEG, that are represented in Fig.
2, a–c, where the evolution of the scattered intensity as
a function of time is readily visible. Each diffusion/
diffraction dataset was then divided by the form factor of
the virus, to obtain the structure factor of the sample that
corresponds to the distribution of the BMV particles (see
FIGURE 1 (Top) Characteristic two-dimensional patterns. (Bottom) Corresponding normalized intensity scattering curves. (a) Static x-ray experiment:
average of 20 two-dimensional scattering patterns (each 50 ms) of a 2.5 mg/ml BMV sample. (b) Experimental form factor I(0,s) of the BMV obtained from the
less concentrated sample (2.5 mg/ml) for 1.17 103, s, 4.62 103 A˚1, and from the 10 and the 20 mg/ml for the s. 4.62 103 A˚1 (average of 20 frames of
50 ms). (c) Example of a kinetic experiment with a sample containing 10 mg/ml BMV and 5% PEG 20 K (w/v). The three frames, chosen from a series of 20
frames (50 ms of acquisition time), were recorded respectively as 180 ms, 5 s, and 1511 s (;25 min) after the mixing. (Top) Progressive formation of
diffraction rings. (Bottom) The corresponding normalized intensity scattering curves show the appearance of Bragg peaks.
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Eqs. 9 and 10). In this way, the contribution of the virus
shape to the signal was removed and the other signals were
emphasized. The resulting curves are represented on Fig. 2,
d–f. As can be seen on the ﬁgures, the division by the form
factor made clearer the diffraction peaks, without revealing
any other signal, and provided at small angles, up to s ¼
0.004 A˚1, plateau-like curves. The lessening of these
plateaus is directly correlated to the decrease of the
concentration of soluble BMV in solution. Note, however,
that the peak heights sometimes decrease at the end of the
experiment, as some microcrystals sediment at the bottom of
the capillary, outside of the x-ray beam. Indeed, this decrease
of the peak height is not due to a partial remixing of the
microcrystals, as no increase of the plateau signal due to
soluble viruses can be seen.
Four series of experiments were selected for more
quantitative analysis, as shown on Fig. 3, top left, 10%
PEG 3 K, 20 mg/ml BMV; Fig. 3, top right, 10% PEG 8 K,
10 mg/ml BMV; Fig. 3, bottom left, 5% PEG 20 K, 10 mg/ml
BMV; and Fig. 3, bottom right, 5% PEG 20 K, 20 mg/ml
BMV. The diffraction peaks emerged at nearly the same
positions, whatever the PEG size and BMV concentration
and were numbered as indicated in Fig, 3, bottom left. The
next step was therefore to check that only one crystal phase
was present and to determine the crystal lattice. As can be
seen on Figs. 2 and 3, the peaks were found to be better
deﬁned with PEG 20 K than with PEG 3 K or 8 K (Fig. 2 f
and Fig. 3, bottom left and bottom right).
Seven peaks can be easily identiﬁed. Four main maxima
are visible in all conditions. They are localized respectively
at s ¼ 0.00445 A˚1, 0.00722 A˚1, 0.00852 A˚1, and 0.0113
A˚1. With BMV concentrations $5 mg/ml, it is readily
visible that the ﬁrst and third maxima have a shoulder at s ¼
0.00506 A˚1 and 0.00887 A˚1, respectively, and that the
fourth maximum is a double peak. An eighth peak
sometimes emerges from the noise at s ¼ 0.0125 A˚1. The
intensity, width, and center of the diffraction peaks were
obtained from a ﬁt with a Gaussian bell curve. The similar
growth with time of these peaks conﬁrms that they all belong
to the same phase. The spacing of the clearly deﬁned
diffraction peaks enabled us to determine the crystalline
lattice of the microcrystals. A linear regression showed that
the spacing follows the ratios O3, O4, O8, O11, O12, O19,
O20, and O24 (see Table 2) which is consistent with a
face-centered cubic lattice. One peak is missing (the peak
corresponding to the O16 reﬂection), yet its position
corresponds to the second zero of the virus form factor.
The unit cell size would then be 391 A˚, and considering that
in the face-centered cubic system molecules are in contact
with each other, the calculation of the diagonal of the faces
reveals a diameter of 276 A˚ for the BMV particles in the cell.
This value is slightly higher than the mean diameter of 264 A˚
obtained previously by ﬁtting with a hollow-sphere model
the experimental form factor of the virus at pH 5.9 (Casselyn
et al., 2001), and probably reﬂects the presence of capsomers
at the virus surface.
As a conclusion of this part, all the features of the
scattering curves when divided by the form factor, i.e., the
plateau at low angles and the series of growing peaks,
consistent with Eq. 10, deﬁnitively conﬁrm that nothing but
soluble viruses and microcrystals can be detected by x rays in
the samples during the time-resolved experiments. The next
step was to analyze the critical nucleus, and then the evolu-
tion with time of each of the two phases.
The critical nucleus
For crystals large enough to be considered as inﬁnite, the
diffracted intensity is a set of d-functions at the nodes of
the reciprocal space. When the crystal shape is of ﬁnite
size, the crystal can be described in real space by the product
of the inﬁnite crystal by a shape function, which is equal to
1 inside the crystal and 0 outside. The scattered amplitude at
each node, shkl, of the reciprocal space is therefore the
convolution product of a d-function by the Fourier transform
of the crystal shape. The intensity around the node may
therefore be written as
IðsÞ ¼ Ihkl expðð4=3Þp2R2gðs shklÞ2Þ; (11)
where Rg is the radius of gyration of the volume occupied by
the crystal.
A Gaussian shape was indeed found adequate to account
for the scattered intensity around each node. The parameters
of the Gaussian peak were determined using the program
PeakFit (SYSTATSoftware, Erkrath,Germany), according to
IðsÞ ¼ Ihkl expðð1=2Þððs shklÞ=sIÞ2Þ; (12)
TABLE 1 Conditions of PEG and BMV mixtures
BMV
concentration
PEG 20 K
2.5%
PEG 20 K
5%
PEG 20 K
10%
PEG 8 K
2.5%
PEG 8 K
5%
PEG 8 K
10%
PEG 3 K
2.5%
PEG 3 K
5%
PEG 3 K
10%
20 mg/ml L yes yes no yes yes no L yes
10 mg/ml no yes yes no yes yes no no yes
5 mg/ml no L yes no L yes no no L
2.5 mg/ml no no L no no L no no no
PEG and BMV mixtures tested. The terms yes and no indicate the samples where diffraction peaks are or are not observed after mixing; L stands for limit.
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where shkl is the center of the Gaussian peak and sI its
standard deviation.
Therefore one has the relationship
Rg ¼
ﬃﬃﬃﬃﬃﬃﬃﬃ
3
8p
2
r 
1
sI
 
: (13)
In this expression, Rg represents the radius of gyration of
the average of the individual microcrystal volumes. The
relationship between this radius of gyration and the average
crystal size depends upon the crystal size distribution and the
crystal geometry. If we assume that Rg gives an estimate of
the average radius of the individual microcrystals, then the
average size D of the crystals is given by the relationship
FIGURE 2 Diffraction peaks forma-
tion as a function of time (indicated in
seconds) and of PEG molecular weight
at concentration 10% (w/v). The labels
(a), (b), and (c) represent, respectively,
the diffracting data of samples contain-
ing PEG 3 K in the presence of 20 mg/
ml BMV, PEG 8 K in presence of 10
mg/ml BMV, and PEG 20 K in
presence of 10 mg/ml BMV. Note that
for PEG 20 K and to a lesser extent for
PEG 8 K a few peaks are already
present at the beginning of the kinetic
experiment, because of microcrystals
stuck to the capillary from the previous
run. The characteristic lobes of the
scattering of soluble viruses are still
visible. The labels (d ), (e), and ( f ) are
the corresponding structure factors (the
scattered intensity divided by the form
factor, to remove the scattering signal
of the virus shape and improve the
visibility of the peaks). Noteworthy is
the fact that the width of the diffraction
peaks decreases with increasing the
PEG molecular weight.
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D  2Rg ¼
ﬃﬃﬃﬃﬃﬃﬃﬃ
3
2p
2
r 
1
sI
 
: (14)
The evolution of the Rg as a function of time correspond-
ing to the four conditions shown in Fig. 3 is plotted in Fig. 4.
That way, the microcrystal radius of gyration Rg was found
to vary from 515 A˚ to 1100 A˚ when using PEG 3 K (Fig. 4,
top left) and from 1000 A˚ to 1390 A˚ when using PEG 8 K
(Fig. 4, top right). With the PEG 20 K, we observed no
evolution of the radius of gyration with time, but the Rg
varies from 1400 A˚ to 1530 A˚ depending upon the virus
concentration (Fig. 4, bottom left and bottom right). It may
seem surprising that the sizes observed are larger with
increasing PEG size, where the supersaturations are larger
and therefore the critical nuclei should be smaller. Yet, the
growth rate of the microcrystals also increases with
supersaturation so that with PEG 8 K and PEG 20 K we
should observe already a mixture of nucleation and growth.
Probably, the growth after nucleation is too fast to be
followed and once formed, each microcrystal rapidly reaches
its ﬁnal size. Of course the size of the critical nuclei may be
smaller than the size of the ﬁrst microcrystals that are
detected in the experiment, whereas the real average ﬁnal
size of the microcrystals may be larger (which is probably
the case of Fig. 4, bottom left and bottom right, where the
larger microcrystals have settled out of the x-ray beam).
Therefore, the size of the critical nuclei should be equal to or
FIGURE 3 Evolution of the diffrac-
tion peaks as a function of time, for
samples containing (top left) 10% PEG
3 K, 20 mg/ml BMV; (top right) 10%
PEG 8 K, 10 mg/ml BMV; (bottom left)
5% PEG 20 K, 10 mg/ml BMV; and
(bottom right) 5% PEG 20 K, 20 mg/ml
BMV. The reﬁnement of the peaks is
visible on top-left panel. The peaks are
numbered as a function of their position
on bottom-left panel (see text).
TABLE 2 Crystalline lattice of the BMV microcrystals
Reﬂections permitted
for a face-centered
cubic system
s-Values
observed sR Peak
(111) O3 0. 00445 0.00443 1
(200) O4 0.00506 0.00511 2
(220) O8 0.00722 0.00723 3
(311) O11 0.00852 0.00847 4
(222) O12 0.00887 0.00886 5
(400) O16 ;0.01 0.01024 —
(331) O19 0.01120 0.01115 g6
(420) O20 0.01138 0.01147
(422) O24 0.01250 0.01253 7
SR are the s-values obtained with a linear regression Ds ¼ 0.0865 103 A˚1
(based on the positions of the peaks reported on Fig. 3, bottom left).
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smaller than the smallest size observed in our experiments,
i.e., a radius of gyration of ;515 A˚. Taking 276 A˚ as the
virus diameter and assuming that 70% of the nucleus volume
is occupied by the virus (in the face-centered cubic system),
one therefore obtains that the smallest spherical microcrystal
contributing to diffraction in Fig. 4, top left, is made of ;36
viruses. The number of viruses in the (possibly nonspherical)
critical nucleus is#36. Such a size, coupled to the solubility
cs (;2.5 mg/ml for 10% PEG 3 K), allows us to estimate the
interfacial free energy. One obtains g # 6.25 105 kBT/A˚
2
from Eq. 4 and the critical activation free energy DG is found
#65 kBT from Eq. 5b. These low values are consistent with
the rapid nucleation and growth obtained at the phase
separation.
Kinetics of crystal nucleation and growth
Microcrystal nucleation and growth can be quantiﬁed by
studying the evolution of the diffracting signal and the
consumption of free BMV. These parameters were analyzed
as a function of BMV concentration, PEG molecular weight,
and concentration, and are also represented on Fig. 4.
The kinetics of formation of the microcrystals can be
followed by considering the evolution as a function of time
of the intensity and shape (width) of the resulting diffraction
peaks. Moreover, as the intensity near the origin is repre-
sentative of the concentration of soluble virus in solution,
the initial plateau value corresponds to the actual BMV con-
centration in the mixture at the beginning of the experiment,
whereas the ﬁnal plateau value is close to the virus solubility
cs, i.e., from 0.1 to 1mg/ml for 10% PEG 20K and 2–3mg/ml
for 10% PEG 3 K. As the samples could not be recovered
after the stopped-ﬂow experiments to measure the concen-
trations in the two phases, a few of the conditions studied
were reproduced in a separate experiment, and the two phases
separated by sedimentation. In a PEG 20 K BMV 20 mg/ml
experiment, the measurement of the optical density of the
supernatant indicated only 0.75 6 0.25 mg/ml of BMV left
in solution. The measurement of the refractive index indi-
cated that 92 6 6% of the PEG was in the supernatant.
The increase of the Bragg peak intensities can be directly
related to two distinct events. The ﬁrst one is the formation of
new nuclei; the second is the growth of existing micro-
crystals. Both of these events imply the decrease of the
concentration of soluble virus in solution, and can be fol-
lowed from the values of the plateau-like curves near the
origin on Fig. 3.
Nucleation processes and crystal growth obtained are not
exactly similar with the three different sizes of PEG as can be
seen on Fig. 4. With PEG 3 K (Fig. 4, top left), the kinetics
clearly show a two-step process that could indicate that the
nucleation phase is distinct from the growth phase. It seems
FIGURE 4 Evolution as a function of
time of the intensity of peak #1, of the
concentration of soluble virus (mea-
sured from the plateau level) and of the
microcrystal radii of gyration (calcu-
lated from the peak width according to
Eq. 13) for the spectra shown in Fig. 3.
(Top left) 10% PEG 3 K, 20 mg/ml
BMV; (top right) 10% PEG 8 K, 10 mg/
ml BMV; (bottom left) 5% PEG 20 K,
10 mg/ml BMV; and (bottom right) 5%
PEG 20 K, 20 mg/ml BMV.
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that for this PEG size, the nucleation occurs in the 12–13 s
after the beginning of the experiment, after which the
increase in signal is due to the diffraction of growing micro-
crystals. As the concentration does not seem to vary anymore,
one can suppose that the increase of the diffraction signal and
of the size of the crystals is due to the fusion of microcrystals.
Fig. 3, bottom left and bottom right, show that with PEG
20 K 5%, the height of the ﬁnal diffraction peaks is twice
higher when using 20 mg/ml BMV than when using only 10
mg/ml. This immediately reveals that the variations of the
peak intensities are due to the increase of the microcrystal
number rather than to the growth of existing ones (a signal
proportional to the square of the number of viruses present in
the crystals would then be expected). The fact that, even if
the height of the diffraction peaks increases for PEGs 8 K
and 20 K, no evolution of their width is observed, conﬁrms
that for both PEGs, nucleation and growth up to a ﬁnal size
are simultaneous. The width of the peaks remains almost
constant as a function of time, but the decrease of the soluble
virus concentration conﬁrms that soluble viruses are used to
form new microcrystals.
To determine the importance of the PEG concentration and
molecular weight, the different results obtained for a unique
concentration of virus, in presence of PEG (8 K or 20 K) at
different concentrations, were compared. Since peak #3 only
corresponds to the 220 reﬂection, it was considered to be the
most relevant for direct comparison between experimental
conditions. The intensity variations of peak #3 for the samples
containing 10 mg/ml BMV combined with 5 or 10% (w/v)
PEG are reported on Fig. 5.
As can be seen on Fig. 5, it is possible to detect the
existence of a lag time for new microcrystals to appear. For
both PEGs, the lag time increases with decreasing PEG
concentration, from 1 s to;8 s for PEG 8 K and from 0.5 s to
;1 s for PEG 20 K. Moreover, as can be seen on the ﬁgure,
the kinetics observed for 5% PEG 20 K and 10% PEG 8 K
are quite similar, indicating that a higher PEG concentration
may compensate for a lower PEG size.
DISCUSSION
Time-resolved SAXS experiments allowed us to follow the
formation of the microcrystalline precipitates of BMV.
Owing to the stopped-ﬂow device, the high brilliance and the
CCD detector of the ID2 beamline at ESRF, the disappear-
ance of the viruses from solution and the simultaneous
growth of diffraction peaks could be observed from the
beginning of crystal nucleation and growth until the end of
the process when no more viruses are available for
crystallization in the solution. Twenty measurements
exponentially spaced in time were registered after the mixing
of different volumes of BMV and PEG, from 180 ms after
mixing until the end of the process, after 10–20 min.
The use of three different sizes of PEG, 3 K, 8 K, and 20
K, conﬁrmed the efﬁciency of this polymer to induce phase
separation and crystallization. It is better and better
documented that these PEG properties directly derive from
the depletion attraction induced by PEG between macro-
molecules. The attraction amplitude increases with the PEG
concentration whereas the attraction range increases with the
PEG size (Vivare`s et al., 2002). In the present experiments,
crystal nucleation and growth were shown to be directly
driven by the strength of the attraction, e.g., at 10 mg/ml
BMV concentration, experiments with 10% PEG 8 K were
quite similar to those with 5% PEG 20 K (Fig. 5) conﬁrming
that a higher concentration of PEG may counterbalance
a smaller size. Yet, the difference in PEG size resulted in an
obvious difference in the x-ray data—the sharpness of the
diffraction peaks at the onset of nucleation was observed to
increase with increasing PEG size, whereas the ﬁnal peak
width was the same. At a given PEG concentration, the BMV
concentration, which determines the supersaturation, was of
course another important factor to control nucleation and
growth. Finally, whatever the PEG size, at 10% PEG
concentration, the BMV solubility as measured from the
scattering curves at the end of the experiments was found to
be quite low, varying from;0.5 mg/ml for PEG 20 K up to 2
mg/ml for PEG 3 K.
In the best x-ray diagrams, up to eight well-differentiated
diffraction peaks could be observed (Figs. 2 and 3). The
positions of the four main peaks had already been de-
termined in our previous studies at LURE (Casselyn et al.,
2001), but at that time the other weaker peaks were not
distinguishable, preventing an accurate determination of the
crystalline lattice. The use of the ID2 beamline at ESRF with
its CCD detector allowed us to obtain a higher resolution.
Moreover, the division of the intensity curves by the form
factor of the virus highlighted the peaks so that a face-
centered cubic lattice, with a unit cell size of 391 A˚ (Table 2)
FIGURE 5 Evolution of the intensity of peaks #3 ﬁtted by a Gaussian
bell-shaped curve, for PEGs 20 K and 8 K 5% and 10% (w/v) in 10 mg/ml
BMV samples. Lag times necessary for microcrystals to appear are indicated
by arrows.
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could be demonstrated. In fact, the value slightly varies with
the PEG size, from 385 A˚ with PEG 3 K, to 390 A˚ with PEG
8 K, up to 391 A˚ with PEG 20 K. Since the microcrystal
growth is slower with PEG 3 K than with higher sizes of
PEG, the formation of better-arranged and more compact
crystals might be favored. Another explanation, suggested
by one of the reviewers, could be the stronger osmotic
pressure applied on the crystals at constant weight fraction
when decreasing PEG size. Cubic lattices are frequently
observed with spherical viruses, yet the face-centered cubic
lattice is particularly reminiscent of what is usually observed
with colloids at the ﬂuid-solid transition. Therefore, the
BMV presents characteristics that are intermediate between
proteins and colloids. The lattice observed here is, however,
different from that of the crystals used for the determination
of the atomic structure of BMV byMcPherson’s team (Lucas
et al., 2001, 2002) which were obtained in different
crystallization conditions and crystallized either in a rhom-
bohedric (R3) or an orthorhombic space group (P212121).
None of these space groups can account for the observed
data. We have reported previously (Casselyn et al., 2001,
2002) that large crystals could be reproducibly obtained in
conditions just below the phase separation curve. However,
high-resolution data of these crystals have not yet been
obtained.
Because of the quasisynchronized formation of a large
number of nuclei, the early stages of crystal nucleation and
growth could be observed. The timescale of the process was
easily followed, either from the decrease of the BMV
concentration in solution or from the growth of the peaks,
which were both representative of the early stages of
crystallization. Such a timescale could not be measured in
usual crystallization conditions where only a few crystals are
obtained after some hours or some days. After a lag time that
seemed to be a function of the supersaturation, diffraction
spots became apparent on the detector and their number
increased until making diffraction rings (Fig. 1, top). The
intensity of the rings went on growing rapidly during the ﬁrst
minute or so and thenmuchmore slowly during;10–20min,
until the virus left in the solution reached its solubility limit
and no evolution of the intensity was further observed, except
sometimes for a decrease of the diffraction signal due to the
sedimentation out of the x-ray beam of the largest micro-
crystals. The lag time necessary for the nuclei to become
visible varies from approximately half a second up to several
seconds, according to the concentration of both PEG and
BMV (Figs. 4 and 5). The radius of gyration of the critical
nuclei was shown to be small,#500 A˚. From the variation of
the intensities of the diffraction peaks as a function of time,
two processes were clearly visible that partially overlap—an
extensive nucleation of microcrystals followed by their
subsequent growth (Figs. 4 and 5). With PEG 20 K 5% the
diffraction peaks evolved continuously during the experi-
ment, to reach a ﬁnal height proportional to the initial virus
concentration, which indicates that the microcrystals go on
forming and that the growth is limited because of the large
number of nuclei. In such a case, the PEG-induced attraction,
rather than the BMV concentration, appears to be the driving
force for crystallization. At the end of the experiments, the
limiting radius of gyration of the microcrystals was shown to
vary from ;1100 to 1700 A˚, according to the PEG size. We
still do not know the shape of the microcrystals, but if they
were spherical, they would be composed of;350 up to 1300
BMV particles.
Finally, no intermediary state could be detected between
solution and crystal, indicating structured nucleation from
the very beginning. The division of the scattered intensity
curves by the form factor of BMV clearly shows that only
two species are present in solution, soluble BMV and
microcrystals. Since the number of nuclei is so large and the
nucleation process is lasting for at least 1 min, the lack of any
other signal is in agreement with a nucleation pathway of
BMV crystalline samples involving only periodic structures.
The experiments also demonstrate that at high supersatura-
tion nucleation can be rather fast, and does not require the
preliminary formation of liquid-like droplets as proposed by
ten Wolde and Frenkel (1997) near a ﬂuid-ﬂuid critical point.
In the colloid ﬁeld, it has been shown that in mixtures of
hard spheres and neutral polymers the type of phase diagram
depends essentially on the ratio, j, of the radius of gyration
of the polymer molecules to the radius of gyration of the
colloidal particles. For j # 0.25, only two phases coexist in
the phase diagram (a ﬂuid phase and a crystal phase),
whereas a triple point (gas, liquid, and crystal), is present for
j $ 0.25 (Illet et al., 1995). In the present work, j is ,0.25
for PEG 3 and 8 K but not for PEG 20 K since the radii of
gyration are, respectively, 23, 40, and 70 A˚ (Devanand and
Selser, 1991). In the present work, only two phases were
observed. Moreover, the polymer concentration range where
the phase separation occurs is much lower than in the
theoretical predictions. Such differences with the colloid
case still remain unexplained.
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